Plaques containing amyloid b-peptides (Ab) are a major feature in Alzheimer's disease (AD), and GM1 ganglioside is an important component of cellular plasma membranes and especially enriched in lipid raft. GM1-bound Ab (GM1/Ab), found in brains exhibiting early pathological changes of AD including diffuse plaques, has been suggested to be involved in the initiation of amyloid fibril formation in vivo by acting as a seed. However, the role of GM1 in amyloid bprotein precursor (APP) processing is not yet defined. In this study, we report that exogenous GM1 ganglioside promotes Ab biogenesis and decreases sAPPa secretion in SH-SY5Y and COS7 cells stably transfected with human APP695 cDNA without affecting full-length APP and the sAPPb levels. We also observe that GM1 increases extracellular levels of Ab in primary cultures of mixed rat cortical neurons transiently transfected with human APP695 cDNA. These findings suggest a regulatory role for GM1 in APP processing pathways. Molecular Psychiatry (2004) 9, 946-952.
Formation of senile plaques, composed of a 4 kDa small peptide-the amyloid b-peptide (Ab)-is one of the hallmarks of Alzheimer's disease (AD). Ab is generated by the consecutive cuts of two proteases, known as b-and g-secretase, 1 which liberate the amyloidogenic peptide from its precursor, the Alzheimer amyloid precursor protein (APP). An alternative cleavage before residue 17 of Ab by a-secretase releases sAPPa and prevents the generation of Ab. Ab aggregation is thought to result in the formation of neurotoxic protofibrils, 2 and the deposition of amyloid plaques. Genetic studies show that increased Ab42 production is associated with inherited familial AD. 1, 3 Factors regulating Ab secretion could thus become very important for the etiology of AD. The predominant cleavage product is sAPPa and this may serve to prevent the production of Ab. 1, 3 The proteolytic processing of APP to sAPP and Ab is regulated by protein kinase C (PKC), 4 protein tyrosine kinase, muscarinic receptors, estrogens and cholesterol. 5 Gangliosides are glycosphingolipids found in the outer leaflet of mammalian plasma membranes, especially abundant on neuronal cell surfaces. GM1, GD1a, GD1b, GT1b are major types of gangliosides found in brain. 6 Gangliosides have been reported to participate in proliferation and differentiation of various types of cell. 7 Many components of the plasma membrane signaling machinery reside within membrane lipid microdomains, or rafts, enriched in sphingolipids and cholesterol. Signal transduction through the plasma membrane is thought to proceed within raft and might be influenced by gangliosides. 8, 9 The ganglioside GM1, enriched in raft, has been well-studied because of its role as the cell surface receptors for viral and bacterial toxins. It has been reported that an increased sialidase activity in the AD brain would result in an increase in gangliosides, preferentially GM1, and significant changes in the ganglioside patterns of AD brains have been reported. 10, 11 GM1 has been found in amyloid plaques and binds to Ab. 12, 13 They discovered GM1-bound Ab in brains exhibiting early pathological changes of AD and suggested that GM1-Ab complexes may serve as a seed for toxic amyloid fibril formation. Recently, Matsuloka et al 14 use GM1 as peripheral agent with high affinity to Ab to reduce brain amyloid load in transgenic mice. Here we found that gangliosides do not only bind to Ab but also clearly stimulate Ab production on a cellular level in cultures of African green monkey epithelial kidney cells (COS7) and human neuroblastoma cells (SH-SY5Y) and in mixed rat cortical neurons, which transfected with human APP695 cDNA. We examined the direct effect of GM1 on APP processing in detail.
Materials and methods

Cell culture and treatment
Mixed cortical neurons were prepared from 14-dayold fetal rats as described. 15 Recombinant Semliki Forest virus (SFV) encoding human APP695 was prepared as described previously. 16 Neurons were infected for 60 or 90 min at 371C under a 5% CO 2 /95% air atmosphere with recombinant SFV-APP695. The virus solution was replaced by maintenance medium. COS7 and SH-SY5Y cell lines both transfected with APP695cDNA, SH-SY5Y-SPA4CT were cultivated in MEM/F-12 medium containing 10% fetal calf serum (FCS), 2 mM L-glutamine, 1% nonessential amino acids and 300 mg/ml Hygromycin (Roche). GM1 purchased from Sigma were dissolved in PBS. Cell culture medium contains no FCS when treated with GM1 for the presence of FCS interfered with GM1 binding to cells. 17 
Antibodies
Monoclonal antibodies W02 (for total Ab and sAPPa), G2-10 (for Ab40) and G2-11 (for Ab42) have been previously described.
18 22C11 (purchased from Sigma) recognizes amino acids 66-81 of the N-terminus on the APP molecule, specific for sAPPa/b and fulllength APP. Polyclonal anti-Ab1-40 antibody 692 equally precipitates Ab and P3.
Cell toxicity
To determine the effect of GM1 on cell toxicity, plasma membrane damage associated with acute cell death was analyzed by measuring the release of the lactate dehydrogenase (LDH) into the medium with the Cytotoxicity Detection Kit (Promega).
RT-PCR
Total RNA was isolated using the Trizol kit according to the manufacturers protocal (Gibco/BRL). Complementary DNA (cDNA) was prepared by reverse transcription (RT) of 1 mg of total RNA according to the manufacturer's protocal (Gibco/BRL). The PCR program was designed according to a sequence including a denaturation step at 951C for 3 min, following by 25 cycles for APP, or 20 cycles for b-actin, each consisting of denaturation at 941C for 30 s, annealing at 601C for APP or 521C for b-actin for 60 s, and elongation at 701C for 60 s. The amplification was terminated by a delay time of 10 min at 721C. The PCR products were separated by electrophoresis on 2% agarose gel that included ethidium bromide (0.1 mg/ml). The specific primers for APP gene were 5 0 CCA AGC TTA TGA GGG GCC GCA AGC AG 3 0 as sense primer, and 5 0 GCG AAT TCC TCT TTG GCG ACG GTG TGC 3 0 as antisense primer (amplify the residues 100-156 of APP695). The specific primers for b-actin were: 5 0 GTG GAC ATC CGC AAA GAC 3 0 as sense primer, and 5 0 AAA GGG TGT AAC GCA ATC AA3 0 as antisense primer defining a 302 base pair target of the human cDNA.
Metabolic labeling and immunoprecipitation
For pulse-chase experiments cells were pretreated with or without 50 mM GM1 for 8 h, labeled with 35 S-methionine 250 mCi/ml for 1 h and chased for different periods of time. Total labeled cellular fulllength APP (APPfl) was determined by lysing cells with RIPA buffer immediately after labeling, followed by immunoprecipitation with 22C11 or W02 (antiAb4-10) and protein G agarose (Sigma). Secreted APPa/b was immunopreciptated from the medium with 22C11. Total Ab, Ab40, Ab42 were immunoprecipitated from the medium with W02, G2-10, G2-11 respectively.
Western blots Medium and cell extracts were analyzed by Western blot as previously described. 18 Detection was made by ECL method (Amersham). Band was acquired using a CCD camera (BioRad) and band intensity was performed by the applied software Quantity One.
Statistical methods
The data were analyzed by ANOVA followed by unpaired Student's t-tests. Values of Po0.05 were considered significant.
Results
Effect of GM1 on APP gene transcription
To test the role of GM1 on APP gene transcription, we measured the ratio of APP/b-actin by RT-PCR method in SY5Y695 cells. There was no significant difference in the ratio indicating that GM1 does not influence the transcription of APP gene (data not shown). GM1 treatment has no cell toxicity, as assessed by LDH released into the media ( Table 1) .
Effect of GM1 on APP turnover
To study the effect of GM1 on the half-life of fulllength APP (APPfl) and the amount of secreted soluble APP (sAPPa/b), we performed pulse-chase experiment in SH-SY5Y cells transfected with APP695. Cells were pretreated with 50 mM GM1 or vehicle for 8 h, then metabolically labeled with 35 S-methionine for 1 h and chased for different periods of time. APPfl and sAPPa/b from the conditioned media were immunoprecipitated with antibody 22C11. No significant difference in APPfl levels between treated and untreated cells was observed either at timepoint 0 or throughout the pulse chase ( Figure 1 , upper half ). Since 22C11 crossreacts with a related protein APLP2, further confirmation of protein specificity was obtained using the APP-specific antibody W02, which recognizes epitopes 4-10 amino SH-SY5Y cell lines were treated with different concentration of GM1 for 8 h. LDH release in the conditioned media was analyzed using the enzymatic assay from Promega, as described by the manufacturer. 
GM1 inhibits the secretion of sAPPa
In the pulse-chase experiment, immunoprecipitation of sAPP from the conditioned medium, however, showed that the secretion of soluble APP products was significantly decreased in GM1 treated cells as compared to the untreated cells ( Figure 1 , bottom half ). Here the sAPP includes both sAPPa and sAPPb. We then evaluated the effect of GM1 on the sAPPa secretion by immunoblotting in the media of COS7 cells stably transfected with APP695 cDNA. Figure 2a illustrates the dose-response pattern of the effects of GM1 on sAPPa after 8 h of GM1 exposure, sAPPa GM1 concentration dependently decreased. Figure 2b shows the time course of the effect of 50 mM GM1 on sAPPa secretion by COS7 cells. In the control condition the amount of sAPPa in the medium increased progressively with time, with a plateau after approx. 8 h. When the cells were exposed to GM1, sAPPa in the medium was decreased relative to the controls, but reached its plateau at approximately the same time. Similar effects were observed with SY5Y695 (data not shown). These results were obtained with the antibody W02, which recognizes the Ab epitopes 4-10. This excludes b-ceavage but includes b 0 (BACE1 cleavage at Glu11, a minor by-product in COS and SH-SY5Y cells) and a-cleavages. To see whether b-secretase product sAPPb was influenced by GM1 treatment, the media of COS7 cell treated with vehicle or GM1 (50 mM) for 8 h were precleared with W02 to discard sAPPa and 22C11 was then used to detect sAPPb and smaller sAPP fragments. An example of immunoblots with these preparations is shown in Figure 2c . GM1 strongly decreased the sAPPa signal but had little effect on the remaining sAPP levels. Since the majority of this cleavage products are sAPPb, it is likely that the decrease in sAPP is not caused by an alteration in sAPPb but sAPPa levels.
GM1 increases Ab production
To examine the effect of GM1 on Ab secretion, COS7 cells stably transfected with APP695 were treated with different concentrations of GM1 for 8 h. Ab in the conditioned media was detected by IP-Western blot using polyclonal antibody 692. Figure 3 shows that Ab increases in a dose-dependent manner by GM1 treatment. Importantly, a parallel increase in short Ab fragments including a-secretase generated P3 was observed, indicating that this GM1 effect is not specific to b-secretase. As Ab and P3 increased simultaneously in COS7 cells, the GM1 induced increase in Ab could be caused by either a parallel increase in a-and b-secretase activity or by a stimulation of g-secretase activity. SP-C99 is a truncated APP molecule that is a poor substrate of asecretase and is not cleaved by b-secretase. SY5Y-SP-C99 has been previously shown to secrete Ab peptides into the culture media. 22 Significantly, GM1 increased Ab generation in a dose-dependent manner (Figure 4) .
It has been shown that most of the Ab released from cell lines terminates at residue 40. However, a small proportion (5-10%) extends to residue 42. It has been postulated that the major pathologic culprit in AD is this subpopulation of Ab, because this longer, more aggregation-prone species deposits preferentially in both sporadic and familial AD brains.
19,20 Then we GM1 regulates APP proteolysis Q Zha et al performed the examinations using SH-SY5Y cells stably transfected with human APP695 in the same set, Ab40 and Ab42 were determined by immunoprecipitation using the monoclonal antibodies G2-10 and G2-11, respectively (Figure 5a ). Both Ab40 and Ab42 increased dose-dependently by GM1 in the range of 10-50 mM. Ab increased slightly when cells were treated with 1 mM GM1. In the presence of 10 mM GM1, Ab40 and Ab42 release was increased to 2.570.35 and 2.670.3 fold of that in the absence of GM1. In the presence of 50 mM GM1, a 5.670.59 and 4.570.51 fold increased Ab40 and Ab42 levels was observed (Figure 5b) . To examine the effect of GM1 on cultured neurons, we expressed the human APP gene in primary rat mixed cortical neurons by infection with SFV encoding the human APP (SFV-APP).
16,21-23 GM1 treatment also resulted in increased Ab secretion ( Figure 6 ). These results showed that ganglioside GM1 strongly increased both Ab40 and Ab42 secretion in neuronal and non-neuronal cells and cultured neurons.
In principle, increased Ab levels in the conditioned media might be due to either increased Ab secretion or decreased degradation. To examine GM1 effect on intracellular Ab, we use SH-SY5Y treated with various concentrations of GM1 for 8 h, both Ab40 and Ab42 levels increased in the detergent soluble pool of the cell lysates ( Figure 7) . To see whether this effect was due to inhibition of Ab degradation, we detect the Ab level after removal of GM1 treatment medium. Ab secretion continuously increased after another 8 h incubation (Figure 8 ). Apparently, increased Ab levels were not due to inhibition of Ab degradation. (40) and P3 (40) in the conditioned medium. 
GM1 regulates APP proteolysis Q Zha et al
Taken together, the above data indicate that GM1 increases Ab generation by affecting g-secretase activity directly or indirectly.
Discussion
Our results demonstrate that exogenous addition of GM1 in cultured cells and neurons enhances Ab production, which are paralleled by inhibition of sAPPa secretion. In addition, we found that GM1 regulates the processing of APP by affecting the activity of g-secretase, demonstrated by SY5Y-SPA4CT cell model. It has no influence on the expression of APP gene by RT-PCR analysis and has little effect of rates of APP turnover by pulse-chase experiment. GM1 is known to have Ab binding affinity, to ensure that the binding of GM1 to Ab did not reduce the sensitivity of the assay because of epitope masking, IP-Western blot was performed on a known concentration of Ab with and without GM1, the epitope of the detection antibody was not masked to any great degree, because IP-Western blot detected 96-105% of added human Ab (data not shown).
Gangliosides are a sialic acid containing complex glycosphingolipids found in most of the vertebrate cells, and are present in high concentrations in the neuron-rich regions of the nervous systems. They are amphophilic in nature because they have both lipids and carbohydrates. The lipid portion of the molecule is embedded in the hydrophobic part of the membrane and its carbohydrate portion extends into the extracellular environment. Topologically, gangliosides are ideally situated to modulate biologic effects on cells through their interactions with various ligands. 24, 25 When administered exogenously, either in vivo or in vitro, they affect several different cellular events. How does GM1 alter APP processing and secretion? The APP processing is complex and includes APP post-translational modifications and the activity of at least three secretases in different subcellular compartments through the secretory as well as endocytic pathways. 26 Fishman et al 27, 28 observed that neuroblastoma cells that contain GM1 were able to metabolize exogenous GM1. Exogenous gangliosides can be incorporated into the plasma membrane in a manner analogous to endogenous gangliosides under appropriate conditions. Wiegandt and co-workers 29, 30 have reported that exogenous gangliosides are taken up by cells, but are incorporated in the plasma membrane in a different way than endogenous gangliosides and are not degraded. They also observed that most of the gangliosides were removed by adding serum or serum albumin to the culture medium. Differences in types of cells used might account for some of these contrasting results. Over many years, extensive studies on the binding to and uptake of gangliosides by biological membranes were performed. In principle, the binding of gangliosides to plasma membranes occurs in three different GM1 regulates APP proteolysis Q Zha et al operationally determined manner: loosely associated micelles removable by serum proteins, a proteinbound, serum-resistant but trypsin-labile ganglioside fraction, and trypsin-stable associated gangliosides largely comprising inserted monomers. 31, 32 The insertion into plasma membranes of gangliosides from their micellar state is a slow process. The maximal incorporation into cells of GM1 was reached after 72 h. The exogenous GM1 that has been incorporated into the outer surface of the plasma membrane becomes internalized. Once inside the cell, some of the GM1 must enter the Golgi apparatus where it is converted to GD1a and some of it must be taken up by lysosomes where it is degraded to GM2. APP is a transmembrane glycoprotein 33 and the APP processing enzymes, or secretases, appear to be membrane associated. 34 The interaction of APP with the secretases are believed to occur within several subcellular compartments, including the endoplasmic reticulum (ER), Golgi stacks, trans-Golgi networks, post-Golgi vesicles, endosomes and plasma membrane. All of the membranes within these compartments contain GM1. Thus, exogenous GM1 may interfere with APP processing in many different subcelluar organelles.
In our study, the GM1 promotes Ab secretion in SY5Y-A4CT cells indicated that GM1 could increase g-secretase activity directly or indirectly. The illusive g-secretase seems to be a complex of multiple integral membrane proteins 35, 36 and it was shown to be raft associated. This finding fits well with recent reports that amyloidogenic processing of the Alzheimer bamyloid precursor protein depends on lipid rafts. 37 Rafts are lateral assemblies of sphingolipids and cholesterol within the membrane. The involvement of rafts in Ab production is further supported by previous work showing that GM1 and cholesterol both bind to Ab and facilitate amyloid fibril formation 12, 13 Rafts are small and highly dispersed at the cell surface and are suggested to contain only a subset of B10-30 protein molecules. 38 Therefore, the likelihood is low that APP and g-secretase are in the same individual raft. For g-cleavage to occur rafts would have to be clustered to get APP and g-secretase into the same raft platform. How and where clustering is accomplished during GM1 uptake from plasma membrane is not yet known. Other such examples of raft-dependent processes are known. The conformational change of the cellular prion protein (PrPc) to its pathogenic scrapie form critically depends on the integrity of rafts. 39 However, more work will be necessary to demonstrate whether g-cleavage of APP is indeed directly dependent on the raft lipid environment.
As for the inhibition of a-secretase cleavage by GM1 there are two possible mechanisms. On the one hand, the stiffening of the membrane due to GM1 loading may decrease sAPPa by inhibiting lateral movement and the required contact between enzyme and substrate. This result is supported by our previous study that there is a GM1 binding site located in the N-terminus of APP, and binding of GM1 to APP N-terminus could result in conformational changes of APP N-terminus such that a-secretase cleavage is inhibited (in preparation). On the other hand, GM1 has been reported to have an inhibitory action on PKC and sAPPa is positively regulated by PKC activation. [40] [41] [42] GM1 may inhibit sAPPa secretion by inhibiting the PKC activity. Both hypotheses require and deserve further experimental work.
Many studies are exploring the roles of molecules such as cholesterol and ganglioside in the formation of Ab plaques. Our study raises the possibility that GM1 increases the level of intracellular Ab and causes a greater extent of Ab secretion into the extracellular space, and thus may contribute to b-amyloid deposition. The above hypothesis remains to be tested in vivo. In conclusion, our results indicate that the processing of APP and generation of Ab can be modulated depending on the cellular content of GM1 ganglioside.
